Loss of Smooth Muscle &agr;-Actin Leads to NF-&kgr;B–Dependent Increased Sensitivity to Angiotensin II in Smooth Muscle Cells and Aortic Enlargement

Rationale: Mutations in ACTA2, encoding the smooth muscle isoform of &agr;-actin, cause thoracic aortic aneurysms, acute aortic dissections, and occlusive vascular diseases. Objective: We sought to identify the mechanism by which loss of smooth muscle &agr;-actin causes aortic disease. Methods and Results: Acta2−/− mice have an increased number of elastic lamellae in the ascending aorta and progressive aortic root dilation as assessed by echocardiography that can be attenuated by treatment with losartan, an angiotensin II (AngII) type 1 receptor blocker. AngII levels are not increased in Acta2−/− aortas or kidneys. Aortic tissue and explanted smooth muscle cells from Acta2−/− aortas show increased production of reactive oxygen species and increased basal nuclear factor &kgr;B signaling, leading to an increase in the expression of the AngII receptor type I a and activation of signaling at 100-fold lower levels of AngII in the mutant compared with wild-type cells. Furthermore, disruption of smooth muscle &agr;-actin filaments in wild-type smooth muscle cells by various mechanisms activates nuclear factor &kgr;B signaling and increases expression of AngII receptor type I a. Conclusions: These findings reveal that disruption of smooth muscle &agr;-actin filaments in smooth muscle cells increases reactive oxygen species levels, activates nuclear factor &kgr;B signaling, and increases AngII receptor type I a expression, thus potentiating AngII signaling in vascular smooth muscle cells without an increase in the exogenous levels of AngII.

[1]  J. Redondo,et al.  Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome , 2017, Nature Medicine.

[2]  Hailong Lu,et al.  Vascular disease-causing mutation R258C in ACTA2 disrupts actin dynamics and interaction with myosin , 2015, Proceedings of the National Academy of Sciences.

[3]  J. Coselli,et al.  Aortic Disease Presentation and Outcome Associated With ACTA2 Mutations , 2015, Circulation. Cardiovascular genetics.

[4]  Minyoung Lee,et al.  Poldip2 controls vascular smooth muscle cell migration by regulating focal adhesion turnover and force polarization. , 2014, American journal of physiology. Heart and circulatory physiology.

[5]  Yunchao Su,et al.  NADPH Oxidase 4 Is Expressed in Pulmonary Artery Adventitia and Contributes to Hypertensive Vascular Remodeling , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Sarah J. Parker,et al.  Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. , 2014, The Journal of clinical investigation.

[7]  M. Rieder,et al.  Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. , 2013, American journal of human genetics.

[8]  D. Milewicz,et al.  Smooth muscle hyperplasia due to loss of smooth muscle α-actin is driven by activation of focal adhesion kinase, altered p53 localization and increased levels of platelet-derived growth factor receptor-β. , 2013, Human molecular genetics.

[9]  Victoria P. Le,et al.  Angiotensin-Converting Enzyme–Induced Activation of Local Angiotensin Signaling Is Required for Ascending Aortic Aneurysms in Fibulin-4–Deficient Mice , 2013, Science Translational Medicine.

[10]  Mei Han,et al.  Phosphorylation of Smooth Muscle 22&agr; Facilitates Angiotensin II–Induced ROS Production Via Activation of the PKC&dgr;-P47phox Axis Through Release of PKC&dgr; and Actin Dynamics and Is Associated With Hypertrophy and Hyperplasia of Vascular Smooth Muscle Cells In Vitro and In Vivo , 2012, Circulation research.

[11]  V. Mathura,et al.  Anatabine lowers Alzheimer's Aβ production in vitro and in vivo. , 2011, European journal of pharmacology.

[12]  D. Judge,et al.  Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism , 2011, Science.

[13]  D. Milewicz,et al.  De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction , 2010, American journal of medical genetics. Part A.

[14]  M. Simionescu,et al.  Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. , 2010, Biochemical and biophysical research communications.

[15]  Zhonghui Xu,et al.  Disruption of SM22 Promotes Inflammation After Artery Injury via Nuclear Factor &kgr;B Activation , 2010, Circulation research.

[16]  N. Deshpande,et al.  Poldip2, a Novel Regulator of Nox4 and Cytoskeletal Integrity in Vascular Smooth Muscle Cells , 2009, Circulation research.

[17]  Robert K. Yu,et al.  Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. , 2009, American journal of human genetics.

[18]  H. Dietz,et al.  p38 MAPK Is an Early Determinant of Promiscuous Smad2/3 Signaling in the Aortas of Fibrillin-1 (Fbn1)-null Mice* , 2009, Journal of Biological Chemistry.

[19]  S. Gunst,et al.  Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction. , 2008, American journal of physiology. Cell physiology.

[20]  B. Pober,et al.  Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome. , 2008, The Journal of clinical investigation.

[21]  Timothy B Sackton,et al.  Mutations in smooth muscle α-actin (ACTA2) lead to thoracic aortic aneurysms and dissections , 2007, Nature Genetics.

[22]  D. Harrison,et al.  Measurement of reactive oxygen species in cardiovascular studies. , 2007, Hypertension.

[23]  D. Sorescu,et al.  Nox4 Is Required for Maintenance of the Differentiated Vascular Smooth Muscle Cell Phenotype , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[24]  A. Brasier,et al.  RhoA Mediates Angiotensin II–Induced Phospho-Ser536 Nuclear Factor &kgr;B/RelA Subunit Exchange on the Interleukin-6 Promoter in VSMCs , 2006, Circulation research.

[25]  Marc K. Halushka,et al.  Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.

[26]  A. Zeidan,et al.  Ablation of SM22α decreases contractility and actin contents of mouse vascular smooth muscle , 2004 .

[27]  Attila Kovacs,et al.  Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency. , 2003, The Journal of clinical investigation.

[28]  Dean Y. Li,et al.  New insights into elastin and vascular disease. , 2003, Trends in cardiovascular medicine.

[29]  B. Hinz,et al.  The NH2-terminal peptide of α–smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo , 2002, The Journal of cell biology.

[30]  R J Schwartz,et al.  Impaired vascular contractility and blood pressure homeostasis in the smooth muscle α‐actin null mouse , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  H. Pahl,et al.  The Anti-inflammatory Sesquiterpene Lactone Helenalin Inhibits the Transcription Factor NF-κB by Directly Targeting p65* , 1998, The Journal of Biological Chemistry.

[32]  R. Mecham,et al.  Novel arterial pathology in mice and humans hemizygous for elastin. , 1998, The Journal of clinical investigation.

[33]  H. Pahl,et al.  Helenalin, an Anti-Inflammatory Sesquiterpene Lactone from Arnica, Selectively Inhibits Transcription Factor NF-κB , 1997 .

[34]  S. Glagov,et al.  A Lamellar Unit of Aortic Medial Structure and Function in Mammals , 1967, Circulation research.

[35]  C. van Breemen,et al.  Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress. , 2010, Vascular pharmacology.

[36]  D. Harrison,et al.  Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. , 2005, American journal of physiology. Heart and circulatory physiology.

[37]  E. Davis,et al.  Smooth muscle cell to elastic lamina connections in developing mouse aorta. Role in aortic medial organization. , 1993, Laboratory investigation; a journal of technical methods and pathology.